Clinical Trial Update: Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 trial evaluating the safety and efficacy of the Plasmodium falciparum LSA-3 malaria vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• LSA-3 malaria vaccine (LSA-3 malaria vaccine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED